Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Clinical trial NCT07300514 · RECRUITING

Trial details

NCT number: NCT07300514
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Maintenance Treatment of Peripheral T-cell Lymphoma

Start date: 2026-03-27
Primary completion: 2028-12-30
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.